SEC Form 4 research
| Issuer | HAEMONETICS CORP |
|---|---|
| Tickers | HAE |
| Reporting owners | 69 |
| Officers and directors | 44 |
| Last public filing | 2026-07-29 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-07-28 | 2026-07-24 | Madaus Martin D | A | 2,538 | Not reported | Not reported |
| 2026-07-28 | 2026-07-24 | Zane Ellen M | A | 2,538 | Not reported | Not reported |
| 2026-07-28 | 2026-07-24 | Pomeroy Claire | A | 2,538 | Not reported | Not reported |
| 2026-07-28 | 2026-07-24 | KROLL MARK W | A | 2,538 | Not reported | Not reported |
| 2026-07-28 | 2026-07-24 | Johnson Lloyd Emerson | A | 2,538 | Not reported | Not reported |
| 2026-07-28 | 2026-07-24 | COYLE MICHAEL J | A | 2,538 | Not reported | Not reported |
| 2026-07-28 | 2026-07-24 | Bryant Diane M | A | 2,538 | Not reported | Not reported |
| 2026-07-28 | 2026-07-24 | ABERNATHY ROBERT E | A | 2,538 | Not reported | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.